FIELD: pharmaceuticals.
SUBSTANCE: claimed group of inventions relates to pharmaceutical composition intended to provide an agent for induced hypometabolism and hypothermia in mammals. Pharmaceutical composition includes the beta-blocker propranolol, sympatholytik reserpine, antianginal drug ivabradine antihistamine drug diphenhydramine, serotonin hydrochloride, neuroleptic agent with hypothermic effect of pericyazine, antithyroid agent propitsil, magnesium sulfate and pharmaceutically acceptable solvent. Agent further comprises a carrier, a fat emulsion, which is selected from the group consisting of lipofundin, smo flipid, interlipid. In another embodiment of the invention, a fat emulsion saturated with an inert gas is used, which is selected from the group consisting of xenon, helium, hexafluoride.
EFFECT: invention provides use of a new agent in emergency medicine.
9 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS COMPRISING A FAT EMULSION (VARIANTS), ITS USE AND A METHOD FOR INCREASING THE RESISTANCE OF A MAMMALIAN ORGANISM TO SUPERCOOLING | 2017 |
|
RU2668375C1 |
| MEANS INCLUDING PERFLUORIDECARBON EMULSION (VARIANTS), ITS USE AND METHOD OF CREATING REVERSIBLE PHARMACOLOGICALLY INDUCED HYPOMETABOLISM AND HYPOTHERMIA | 2017 |
|
RU2669398C1 |
| AGENT INCLUDING CYCLIC GLUCOSE OLIGOMER (OPTIONS), ITS APPLICATION AND METHOD OF CREATING REVERSIBLE PHARMACOLOGICALLY INDUCED HYPOMETABOLISM AND HYPOTHERMIA | 2017 |
|
RU2669399C1 |
| METHOD OF INHIBITING TUMOUR GROWTH IN MAMMAL | 2018 |
|
RU2713153C1 |
| USE OF XENON IMMOBILIZED IN CARRIER IN AGENT FOR INCREASING BODY RESISTANCE TO HYPOXIA | 2018 |
|
RU2696100C1 |
| AGENT, ITS USE AND METHOD OF CREATING REVERSIBLE PHARMACOLOGICALLY INDUCED HYPOMETABOLISM AND HYPOTHERMIA | 2017 |
|
RU2669400C1 |
| AGENT COMPRISING A PERFLUOROCARBON EMULSION (OPTIONS), ITS APPLICATION AND METHOD FOR IMPROVING RESISTANCE OF MAMMAL ORGANISM TO SUPERCOOLING | 2017 |
|
RU2665964C1 |
| AGENT, ITS APPLICATION AND METHOD FOR IMPROVING RESISTANCE OF MAMMAL ORGANISM TO SUPERCOOLING | 2017 |
|
RU2665963C1 |
| NOVEL ISOPULEGOL-BASED AGENTS INDUCING HYPOTHERMIA IN ANIMALS | 2023 |
|
RU2814731C1 |
| MEDICINAL AGENTS APPLIED FOR CONTINUOUS POST ACUTE STROKE THERAPY | 2003 |
|
RU2327454C2 |
